Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel U Dignass

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Digestive Diseases (Basel, Switzerland)|September 30, 2009
Management of inflammatory bowel diseases during pregnancyAxel U Dignass, Franz Hartmann, Andreas Sturm, et al.
International Journal of Colorectal Disease|June 6, 2003
Rescue therapy with tacrolimus in a patient with toxic megacolonMaria Pascu, Andrea R Müller, Bertram Wiedenmann, et al.
World Journal of Gastroenterology|March 29, 2021
Use of granulocyte/monocytapheresis in ulcerative colitis: A practical review from a European perspectiveEugeni Domènech, Joan-Ramon Grífols, Ayesha Akbar, et al.
Inflammatory Bowel Diseases|May 20, 2008
Galectin-2 and -4, but not galectin-1, promote intestinal epithelial wound healing in vitro through a TGF-beta-independent mechanismDaniela Paclik, Katrin Lohse, Bertram Wiedenmann, et al.
Scandinavian Journal of Gastroenterology|February 9, 2019
Indirect comparison of vedolizumab and adalimumab for biologic-naive patients with ulcerative colitisAxel U Dignass, Britta Siegmund, Ralf Goertz, et al.
Scandinavian Journal of Gastroenterology|September 17, 2005
Mesalamine promotes intestinal epithelial wound healing in vitro through a TGF-beta-independent mechanismDaniel C Baumgart, Karin Vierziger, Andreas Sturm, et al.
Plos One|February 2, 2012
Selective non-steroidal glucocorticoid receptor agonists attenuate inflammation but do not impair intestinal epithelial cell restitution in vitroKerstin C Reuter, Stefan M Loitsch, Axel U Dignass, et al.
World Journal of Gastroenterology|July 9, 2021
Chronic intestinal failure and short bowel syndrome in Crohn's diseaseAysegül Aksan, Karima Farrag, Irina Blumenstein, et al.
The American Journal of Gastroenterology|April 1, 2006
Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-upDaniel C Baumgart, Jan P Pintoffl, Andreas Sturm, et al.
Digestion|October 16, 2002
Lisofylline and lysophospholipids ameliorate experimental colitis in ratsAndreas Sturm, Jörg Zeeh, Thomas Sudermann, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Digestive Diseases (Basel, Switzerland)|September 30, 2009
Management of inflammatory bowel diseases during pregnancyAxel U Dignass, Franz Hartmann, Andreas Sturm, et al.
International Journal of Colorectal Disease|June 6, 2003
Rescue therapy with tacrolimus in a patient with toxic megacolonMaria Pascu, Andrea R Müller, Bertram Wiedenmann, et al.
World Journal of Gastroenterology|March 29, 2021
Use of granulocyte/monocytapheresis in ulcerative colitis: A practical review from a European perspectiveEugeni Domènech, Joan-Ramon Grífols, Ayesha Akbar, et al.
Inflammatory Bowel Diseases|May 20, 2008
Galectin-2 and -4, but not galectin-1, promote intestinal epithelial wound healing in vitro through a TGF-beta-independent mechanismDaniela Paclik, Katrin Lohse, Bertram Wiedenmann, et al.
Scandinavian Journal of Gastroenterology|February 9, 2019
Indirect comparison of vedolizumab and adalimumab for biologic-naive patients with ulcerative colitisAxel U Dignass, Britta Siegmund, Ralf Goertz, et al.
Scandinavian Journal of Gastroenterology|September 17, 2005
Mesalamine promotes intestinal epithelial wound healing in vitro through a TGF-beta-independent mechanismDaniel C Baumgart, Karin Vierziger, Andreas Sturm, et al.
Plos One|February 2, 2012
Selective non-steroidal glucocorticoid receptor agonists attenuate inflammation but do not impair intestinal epithelial cell restitution in vitroKerstin C Reuter, Stefan M Loitsch, Axel U Dignass, et al.
World Journal of Gastroenterology|July 9, 2021
Chronic intestinal failure and short bowel syndrome in Crohn's diseaseAysegül Aksan, Karima Farrag, Irina Blumenstein, et al.
The American Journal of Gastroenterology|April 1, 2006
Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-upDaniel C Baumgart, Jan P Pintoffl, Andreas Sturm, et al.
Digestion|October 16, 2002
Lisofylline and lysophospholipids ameliorate experimental colitis in ratsAndreas Sturm, Jörg Zeeh, Thomas Sudermann, et al.
Pageof 4